Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page
- ChecktodayChange DetectedThe page revision number was updated from v3.6.3 to v3.6.4, indicating a small update to the page framework rather than the study content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Publications section now includes a complete bibliographic entry for the SKYSCRAPER-06 publication (Socinski et al.), JAMA Oncol. 2026;12(6):619-627, DOI 10.1001/jamaoncol.2026.0818. The earlier Online ahead of print entry (April 30, 2026; e260818) has been removed.SummaryDifference0.0%

- Check43 days agoChange DetectedNew sections to guide users have been added ('No longer looking for participants', 'How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a new revision label v3.6.0 appears. The heading 'Intervention / Treatment' was replaced by 'Intervention/Treatment', and the prior revision label v3.5.5 was removed.SummaryDifference0.2%

- Check50 days agoChange DetectedResults have been posted for the study, and the page now notes 127 locations. The update also introduces detailed outcome definitions for progression-free survival (PFS) and overall survival (OS), along with associated measurement timelines and related data elements.SummaryDifference2%

- Check57 days agoChange DetectedThe study's publication citation for the Phase 3 SKYSCRAPER-06 trial was updated to include the online identifier e260818 and the DOI, replacing the previous entry that did not include the identifier.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now lists Revision: v3.5.4, replacing the previous v3.5.3, indicating an update to the page's revision rather than a modification to the clinical trial details.SummaryDifference0.0%

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.